These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 793956)

  • 1. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.
    Schalm SW; Summerskill WH; Gitnick GL; Elveback LR
    Gut; 1976 Oct; 17(10):781-6. PubMed ID: 793956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment of HBsAg-positive chronic liver disease: significance of HBeAg.
    Tage-Jensen U; Aldershvile J; Schlichting P
    Hepatology; 1985; 5(1):47-9. PubMed ID: 3881331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease.
    Chiaramonte M; Heathcote J; Crees M; Sherlock S
    Gut; 1977 Jan; 18(1):1-6. PubMed ID: 838398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis BS-antigen and hepatis BS-antibodies in partners of HBSAg-positive patients with chronic liver diseases. A contribution to the contagiousness of hepatitis B].
    Henning H; Schuff-Werner P
    Med Klin; 1976 Jan; 71(4):163-7. PubMed ID: 1250197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology and localization of viral antigens in the liver of HBsAg positive homosexuals.
    Paradinas FJ; Davies DR; Supran EM; Viola L; Marigold JH
    Histopathology; 1981 Nov; 5(6):623-37. PubMed ID: 7319481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of HBsAg in chronic hepatic diseases].
    Zavate O; Ivan A; Bivol A; Lungu I; Schneer J; Mardare G
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(4):581-7. PubMed ID: 613403
    [No Abstract]   [Full Text] [Related]  

  • 10. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
    Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
    G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
    [No Abstract]   [Full Text] [Related]  

  • 11. Inefficacy of immunosuppressive treatment in HBSAg-positive, delta-negative, moderate chronic active hepatitis in children.
    Vajro P; Orso G; D'Antonio A; Greco L; Fontanella A; Loffredo G; Oggero V; Buffolano W
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):26-31. PubMed ID: 3884766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive treatment of HBs-antigen positive and negative chronic-active hepatitis (author's transl)].
    Meyer KH
    Dtsch Med Wochenschr; 1978 May; 103(21):887-92. PubMed ID: 648378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
    Czaja AJ
    Hepatology; 1990 Jun; 11(6):1044-9. PubMed ID: 2365282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
    Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
    Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HBsAg in the hepatocytes in chronic liver diseases].
    Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD; Zotina MM
    Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
    Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
    Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
    Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
    Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage.
    Hess G; Manns M; Hütteroth TH; Meyer zum Büschenfelde KH
    Digestion; 1987; 36(1):47-54. PubMed ID: 3556804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of chronic hepatitis (author's transl)].
    Arnold W; Meyer zum Büschenfelde KH
    Leber Magen Darm; 1981 Apr; 11(2):73-80. PubMed ID: 6164895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.